4333 Corbett Drive, Suite 1082
Fort Collins, CO
80525
Statera Biopharma, Inc. was previously know as Cleveland Biolabs, Inc. and was founded in 2003. In July 2021 the name was changed from Cleveland Biolabs, Inc. to Cytocom, Inc. and then changed to Statera Biopharma Inc. in September 2021.
The company is incorporated in Delaware.
The company has been public since 2006.
The company’s fiscal years ends December 31st.
The company’s common stock is listed on the NASDAQ Market under the symbol “STAB”,
Continental Stock Transfer & Trust Company
1 State Street Plaza
30th Floor
New York, NY 10004
212-509-4000
www.continentalstock.com
Continental Stock Transfer & Trust Company
1 State Street Plaza
30th Floor
New York, NY 10004
212-509-4000
www.continentalstock.com
To change the address on your shareholder account you must send both your old and new addresses to our transfer agent, Continental Stock Transfer & Trust Company 1 State Street Plaza 30th Floor New York, NY 10004 212-509-4000 www.continentalstock.com
BF Borgers CPA
To find out more about Statera Biopharma visit their webpage at www.staterabiopharma.com.
Statera Biopharma’s press release archive can be viewed under the “Press Release” section of the “Investors” page and financial reports are available under the “SEC Filings” section of the “Investors” page located at our website: www.staterabiopharma.com.
Statera Biopharma’s SEC Filings can be found on www.sec.gov and are also available under the “SEC Filings” section of the “Investors” page located at our website www.staterabiopharma.com.
ir@staterabiopharma.com
Copyright 2024 Statera Biopharma, Inc.